CEP Magazine
Should Highly Regulated Public Companies Have Board-Level Compliance Committees?
November 2021
In this CEP Magazine article, Sidley partners Holly J. Gregory and Paul E. Kalb, MD, the co-chair of Sidley’s Executive Compensation and Corporate Governance practice and the global head of Sidley’s Healthcare and FDA Group, respectively, discuss the considerations evaluating whether highly regulated public companies should have board-level compliance committees.
Copyright 2021 CEP Magazine, a publication of the Society of Corporate Compliance and Ethics (SCCE).
Offices
Capabilities
Suggested News & Insights
Sidley Represents Great Lakes In Its US$1.5 Billion Acquisition by SaltchukFebruary 11, 2026Shareholder Engagement in Flux: Recent Developments and Practical ImplicationsFebruary 10, 2026Sidley Represents Lead Arranger in US$1 Billion Financing to Navitas and Rockhopper for First-Ever Development of the Falklands Islands Sea Lion FieldFebruary 9, 2026Shareholder Engagement in Flux: Recent Developments and Practical ImplicationsFebruary 7, 2026Delaware Supreme Court Makes Earnouts Less Risky for Buyers – Earnout Decision Partially Reversed Because Buyer Did Not Have to Pursue an Alternative Regulatory PathwayFebruary 5, 2026Eleventh Circuit Loosens Loss Causation in High-Profile Election-Interference Securities SuitFebruary 3, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory